Literature DB >> 6215340

Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.

H D Haubeck, E Kölsch.   

Abstract

Initial stages of tumour growth are not easily accessible to investigation. Therefore an experimental procedure was developed to mimic tumorigenesis as closely as possible. BALB/c mice received intraperitoneally exponentially increasing numbers of irradiated syngeneic ADJ-PC-5 plasmacytoma cells. The initial injection began with two cells per mouse and according to the generation time of this tumour, subsequent doses were doubled until mice had received up to 10(5) tumour cells. At various stages of treatment, peritoneal exudate cells (PEC) and spleen cells (SC) were tested for either cytotoxicity or specific suppression of induction of a primary in vitro T-cell cytotoxic response (CTL) of BALB/c spleen cells against ADJ-PC-5 plasmacytoma cells. No cytotoxic PEC were found. Instead, PEC from mice in which the final tumour cells number had reached or exceeded 10(3) irradiated ADJ-PC-5 cells, induced complete suppression of this primary in vitro CTL. Specificity was found both in the induction and effector phase of suppression. Specific suppression was mediated by Thy-1.2+ cells and amplified by non-specific suppression through adherent cells. The data arae discussed in context with previous findings on the in vivo immunogenicity and tolerogenicity of the ADJ-PC-5 plasmacytoma. They suggest that induction of T suppressor (Ts) cells might be an early event in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215340      PMCID: PMC1555547     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.

Authors:  S Fujimoto; M I Greene; A H Sehon
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

2.  Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.

Authors:  S Fujimoto; M I Greene; A H Sehon
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

3.  Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.

Authors:  M Röllinghoff; B T Rouse; N L Warner
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

4.  Differential reactivity of mice to alloantigens associated with the D and K end of H-2: preliminary studies with bone marrow and lymphoma grafts.

Authors:  E Bonmassar; A Goldin; G Cudkowicz
Journal:  Transplantation       Date:  1971-10       Impact factor: 4.939

5.  Effect of intraperitoneal pristane on established immunity to the adj-PC-5 plasmacytoma.

Authors:  M Potter; J L Walters
Journal:  J Natl Cancer Inst       Date:  1973-09       Impact factor: 13.506

6.  Immunogenicity, antigenicity and mechanisms of tumor rejection of mineral-oil-induced plasmacytomas in syngeneic BALB/c mice.

Authors:  J L McCoy; J H Dean; L W Law; J Williams; N T McCoy; B J Holiman
Journal:  Int J Cancer       Date:  1974-08-15       Impact factor: 7.396

7.  Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

Authors:  H O Sjögren; I Hellström; S C Bansal; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

8.  Characterization of suppressor cells in mice bearing syngeneic mastocytoma.

Authors:  F Takei; J G Levy; D G Kilburn
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

9.  Correlation of "sneaking through" of tumor cells with specific immunological impairment of the host.

Authors:  R Mengersen; R Schick; E Kölsch
Journal:  Eur J Immunol       Date:  1975-08       Impact factor: 5.532

10.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

View more
  7 in total

Review 1.  Role of the regional lymph node in cancer metastasis.

Authors:  T Tachibana; K Yoshida
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

2.  Selective in-vitro activation of BALB/c T suppressor lymphocytes specific for syngeneic ADJ-PC-5 plasmacytoma cells.

Authors:  H D Haubeck; I Minkenberg; E Kölsch
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

3.  A Dynamic Model of Immune Responses to Antigen Presentation Predicts Different Regions of Tumor or Pathogen Elimination.

Authors:  Eduardo D Sontag
Journal:  Cell Syst       Date:  2017-01-26       Impact factor: 10.304

4.  Immunotherapy in the treatment of acute myelogenous leukemia (AML): rationale, results and future prospects.

Authors:  D Urbanitz; T Büchner; H Pielken; J van de Loo
Journal:  Klin Wochenschr       Date:  1983-10-03

5.  A chemical carcinogen, 3-methylcholanthrene, alters T-cell function and induces T-suppressor cells in a mouse model system.

Authors:  L J Alfred; A Wojdani; M Nieto; R Perez; G Yoshida
Journal:  Immunology       Date:  1983-10       Impact factor: 7.397

6.  Modulation of cellular anti-tumour responses by tumour-specific T suppressor lymphocytes.

Authors:  H D Haubeck; R Stutenkemper; E Kölsch
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

7.  Induction of tolerance to a murine fibrosarcoma in two zones of dosage--the involvement of suppressor cells.

Authors:  W H McBride; S E Howie
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.